Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study

Tregs are able of suppressing tumor-specific effector cells, such as lymphocytes CD8+, CD4+ and Natural Killer cells. Different drugs, especially different schedules of administration, like metronomic chemotherapy (mCHT), seem to be able to increase anticancer immunity, by acting on downregulation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Pepe, F. F., Cazzaniga, M. E., Baroni, S., Riva, F., Cicchiello, F., Capici, S., Cogliati, V., Maggioni, C., Cordani, N., Cerrito, M. G., Malandrin, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446532/
https://www.ncbi.nlm.nih.gov/pubmed/36068484
http://dx.doi.org/10.1186/s12885-022-10031-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446532/
https://www.ncbi.nlm.nih.gov/pubmed/36068484
http://dx.doi.org/10.1186/s12885-022-10031-6

Ejemplares similares